Understanding heart toxicity from cancer treatments using stem cells
iPSC Processing Core
This study is looking at how some cancer treatments can affect the heart by using special stem cells, and it aims to help make cancer therapies safer for patients like you.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10935738 on NIH RePORTER |
What this research studies
This research focuses on the use of induced pluripotent stem cells (iPSCs) to investigate the heart-related side effects of cancer therapies. By creating and analyzing these stem cells, researchers aim to better understand how certain cancer treatments can lead to cardiotoxicity. The project provides essential resources and expertise to support various related studies, ultimately aiming to improve patient safety and treatment outcomes. Patients may benefit from advancements in personalized medicine and targeted therapies that minimize heart risks.
Who could benefit from this research
Good fit: Ideal candidates for this research include cancer patients who are at risk of experiencing heart toxicity from their treatments.
Not a fit: Patients who do not have cancer or those whose treatments do not involve cardiotoxic agents may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer cancer treatments with reduced heart-related side effects.
How similar studies have performed: Previous research has shown promise in using iPSCs to study drug effects, indicating potential for success in this novel approach.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Sallam, Karim — Stanford University
- Study coordinator: Sallam, Karim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.